Free Call: 1800 792 676
Swanson Reed News
R&D Tax Incentive Crackdown For Software Claims
December 4th, 2018Reports have emerged in the media recently of software development companies that have been subject to adverse R&D Tax Compliance proceedings: Airtasker hit by R&D incentive tax crackdown that threatens tech firms Whilst the benefits available under the R&D Tax Incentive are significant, these reports affirm the need to ensure R&D claims are completed with diligence, and in accordance with the current reporting expectations. Recent publications from ATO and AusIndustry on software development activities have highlighted current regulatory compliance focuses, […]
Companies that have the best reputation as innovators aren’t necessarily those that spend the most on R&D
November 9th, 2018Despite Switzerland being known as one of the most innovative nations, latest reports have shown a 10% decline in the country’s research and development spending. This comes as a surprise due to the fact that worldwide R&D expenditure has reached an all-time high of $782 billion. The biggest Swiss companies invested $27.5 billion into R&D in 2018. The majority of the decline has come from Basel-based giant pharmaceutical companies Roche and Novartis. Roche spent around $1 billion less on R&D […]
Government commitment to pioneer in the life sciences industry by investing into research and development
November 7th, 2018In 2016 the Johnson & Johnson Partnering Office was launched to enable innovative research and development (R&D) for Queensland’s life sciences industry. The R&D facility is housed at Queensland University of Technology’s (QUT) Institute of Health and Biomedical Innovation. The R&D centre serves as a strong platform to identify and nurture life science and research collaborations. Following on from the launch in 2016, the Queensland government has now announced a significant extension of the Johnson & Johnston R&D Office at […]
Cosmetic brand Cellmid Limited has received an $808,000 research and development grant
November 1st, 2018The functional cosmetics brand, Cellmid Limited has received an $808,000 research and development grant under the tax incentive scheme from the Australian Taxation Office. Cellmid is an Australian life sciences accelerator with lead programs in multiple disease indications. The company holds the largest and most comprehensive portfolio of intellectual property relating to the novel targets midkine (MK) and FGF5, which are growth promoting protein supplements and products. After Cellmid generated $5.64 million in revenue for FY18 and continues to rapidly […]
Categories
- ATO Guidance and Materials
- AusIndustry Guidance and Materials
- Case Law
- For Accountants
- General Information
- Government Policy and Treasury
- Industry Specific Issues
- Interpretative Decisions
- Legislation and Parliamentary Matters
- R&D Tax Credit
- R&D Tax Funding Strategies
- R&D Tax Loans
- Tax Determinations
Archives
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- September 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- May 2013
- April 2013
- March 2013
- September 2012
- August 2012
- June 2012
Quick Contact
News & Research
News & Research
News & ResearchCSL Moves Up International Biotech Market Capitalisation Rankings Driven By R&D Investment
A report in the Australian Financial Review has highlighted the remarkable performance of CSL over recent years, largely due to the company’s investment in R&D Activity. The report has highlighted: CSL’s share price has increased more than 50% during 2019, […]
In December 2019, Fintech Australia released its response to the Financial Technology and Regulatory Technology Senate inquiry. Their committee voiced concerns regarding the Government’s plan to cut $1.35B from the R&D Tax Incentive and stated that the current definition of […]
